- J&J multiple myeloma drug gains edge in earlier stage diseaseThe latest results studying Talvey in combination with Darzalex Faspro support J&J’s efforts to expand the immunotherapy's use.BioPharma Dive · 1mo ago↗ source
- Celiac disease is entering a new era of therapeutic innovationFor the ~1 in 100 people living with celiac, the burden of disease extends far beyond their plate.BioPharma Dive · 1mo ago↗ source
- Planning a successful pivot from lab to clinicFor sterile injectables, key early decisions can have a significant impact on the products’ development.BioPharma Dive · 1mo ago↗ source